Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinics in Liver Disease|November 13, 2017
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver TransplantationDanielle Carter, Douglas T Dieterich, Charissa Chang
Hepatology (Baltimore, Md.)|March 5, 2004
Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trialsStephen H Caldwell, Charissa Chang, B Gail Macik
Seminars in Liver Disease|October 15, 2009
Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone useKaiser Raja, Swan N Thung, M Isabel Fiel, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 11, 2013
Lamivudine resistance leading to de novo hepatitis B infection in recipients of hepatitis B core antibody positive liver allograftsJennifer Leong, Patrick Coty, M Isabel Fiel, et al.
Transplantation Direct|December 26, 2018
Hemophagocytic Lymphohistiocytosis Due to Primary HHV-8 Infection in a Liver Transplant RecipientGabriel M Cohen, Arielle L Langer, Hamid Sima, et al.
Clinics and Research in Hepatology and Gastroenterology|July 24, 2013
Benign hepatocellular nodules: what have we learned using the patho-molecular classificationChristine Sempoux, Charissa Chang, Annette Gouw, et al.
Transplantation|September 11, 2009
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplantHatef Massoumi, Hussein Elsiesy, Viktoriya Khaitova, et al.
Journal of Hepatology|January 22, 2013
Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communitiesPonni V Perumalswami, Stephanie H Factor, Luciano Kapelusznik, et al.
Viruses|October 28, 2023
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated CirrhosisSteven Flamm, Eric Lawitz, Brian Borg, et al.
Journal of Hepatology|January 30, 2017
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCCRiccardo Lencioni, Robert Montal, Ferran Torres, et al.
Pageof 2